These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24788398)

  • 1. Update on the molecular diagnosis and targeted therapy of thyroid cancer.
    Liu M; Ruan M; Chen L
    Med Oncol; 2014 Jun; 31(6):973. PubMed ID: 24788398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.
    Albarel F; Conte-Devolx B; Oliver C
    Ann Endocrinol (Paris); 2012 Jun; 73(3):155-64. PubMed ID: 22503804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of thyroid tumors.
    Bhaijee F; Nikiforov YE
    Endocr Pathol; 2011 Sep; 22(3):126-33. PubMed ID: 21739166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of thyroid tumors.
    Nikiforov YE
    Mod Pathol; 2011 Apr; 24 Suppl 2():S34-43. PubMed ID: 21455199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnosis of carcinomas of the thyroid gland.
    de Biase D; Visani M; Pession A; Tallini G
    Front Biosci (Elite Ed); 2014 Jan; 6(1):1-14. PubMed ID: 24389136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
    Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
    Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics.
    Leeman-Neill RJ; Brenner AV; Little MP; Bogdanova TI; Hatch M; Zurnadzy LY; Mabuchi K; Tronko MD; Nikiforov YE
    Cancer; 2013 May; 119(10):1792-9. PubMed ID: 23436219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene abnormalities in thyroid cancer].
    Namba H; Yamashita S
    Nihon Rinsho; 2007 Nov; 65(11):1967-72. PubMed ID: 18018556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic implications from molecular testing of thyroid cancer.
    Ozgursoy OB; Eisele DW; Tufano RP
    Otolaryngol Clin North Am; 2014 Aug; 47(4):595-607. PubMed ID: 25041960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists.
    Salajegheh A; Petcu EB; Smith RA; Lam AK
    Postgrad Med J; 2008 Feb; 84(988):78-82. PubMed ID: 18322127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.
    Yip L; Nikiforova MN; Yoo JY; McCoy KL; Stang MT; Armstrong MJ; Nicholson KJ; Ohori NP; Coyne C; Hodak SP; Ferris RL; LeBeau SO; Nikiforov YE; Carty SE
    Ann Surg; 2015 Sep; 262(3):519-25; discussion 524-5. PubMed ID: 26258321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnostics and predictors in thyroid cancer.
    Nikiforova MN; Nikiforov YE
    Thyroid; 2009 Dec; 19(12):1351-61. PubMed ID: 19895341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis of differentiated thyroid cancer (papillary and follicular)].
    Maciel RM; Kimura ET; Cerutti JM
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):691-700. PubMed ID: 16444351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules.
    Eszlinger M; Krogdahl A; Münz S; Rehfeld C; Precht Jensen EM; Ferraz C; Bösenberg E; Drieschner N; Scholz M; Hegedüs L; Paschke R
    Thyroid; 2014 Feb; 24(2):305-13. PubMed ID: 23837487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany.
    Eszlinger M; Böhme K; Ullmann M; Görke F; Siebolts U; Neumann A; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Ruschenburg I; Paschke R
    Thyroid; 2017 Mar; 27(3):402-411. PubMed ID: 28071986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
    Witt RL
    Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations in differentiated thyroid cancers.
    Salehian B; Liu Z
    Endocr Metab Immune Disord Drug Targets; 2009 Sep; 9(3):257-68. PubMed ID: 19594419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome.
    Tavares C; Melo M; Cameselle-Teijeiro JM; Soares P; Sobrinho-Simões M
    Eur J Endocrinol; 2016 Apr; 174(4):R117-26. PubMed ID: 26510840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnostics of thyroid tumors.
    Nikiforov YE
    Arch Pathol Lab Med; 2011 May; 135(5):569-77. PubMed ID: 21526955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAS Mutations, and RET/PTC and PAX8/PPAR-gamma Chromosomal Rearrangements Are Also Prevalent in Benign Thyroid Lesions: Implications Thereof and A Systematic Review.
    Najafian A; Noureldine S; Azar F; Atallah C; Trinh G; Schneider EB; Tufano RP; Zeiger MA
    Thyroid; 2017 Jan; 27(1):39-48. PubMed ID: 27750019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.